Literature DB >> 9059530

Effects of low-flow ischemia on the positive inotropic action of angiotensin II in isolated rabbit and rat hearts.

J R Libonati1, F R Eberli, H W Sesselberg, C S Apstein.   

Abstract

OBJECTIVE: Angiotensin II (ANG II) has recently been reported to increase inotropy in adult rabbit myocytes by a mechanism of alkalinization and consequent increased myofilament sensitivity to calcium. Accordingly, we tested the hypothesis that ANG II would have a greater inotropic effect during ischemic conditions than it would during normoxia, since ischemia-induced intracellular acidosis contributes to ischemic contractile depression by decreasing myofilament calcium sensitivity.
METHODS: We studied the effects of ANG II in isolated, red-blood-cell-perfused, isovolumic rat and rabbit hearts during normoxic perfusion conditions and at graded reductions in coronary perfusion pressure (CPP). At each level of perfusion, ANG II was infused at progressively increasing concentrations ranging from 10(-11) to 10(-5) M. The maximal effective ANG II concentration was 10(-7) M.
RESULTS: Our studies show that ANG II caused comparable absolute increases in isovolumic LV developed pressure in normoperfused and hypoperfused rabbit hearts. However, since contractile function was markedly depressed in ischemic hearts prior to ANG II administration, the relative inotropic response to ANG II was significantly greater during ischemia than normoxia. Similarly, ANG II had no positive inotropic effect in the rat during normoxia, but increased contractility during ischemia. To assess specifically the potential of ANG II to reverse the negative inotropy of acidosis, normoxic non-ischemic rat hearts were perfused with a hypercarbic acidotic perfusate (pH = 7.1). During the hypercarbic perfusion when contraction was depressed by acidosis, ANG II [10(-7)]M increased LV developed pressure by 19% and +dP/dt by 27% (P < 0.05), in contrast to its lack of intropic effect at a normal pH. The positive inotropic effect observed in rat hearts with ANG II during ischemia was significantly attenuated (P < 0.001) by concomitant infusion with amiloride, 5-(N-ethyl-N-isopropyl) (EIPA), a Na+/H+ exchange inhibitor.
CONCLUSIONS: We conclude that during normoxia, ANG II has a different inotropic potency in rabbits from that in rats. In both species, the relative inotropic responsiveness of ANG II is potentiated during low-flow ischemia. These results are consistent with a relative intracellular alkalinization that occurs secondary to ANG II's action to stimulate Na+/H+ exchange.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059530     DOI: 10.1016/s0008-6363(96)00185-x

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  5 in total

1.  Cardiac remodeling and function following exercise and angiotensin II receptor antagonism.

Authors:  Joseph R Libonati
Journal:  Eur J Appl Physiol       Date:  2011-12-06       Impact factor: 3.078

2.  Regulation of L-type inward calcium channel activity by captopril and angiotensin II via the phosphatidyl inositol 3-kinase pathway in cardiomyocytes from volume-overload hypertrophied rat hearts.

Authors:  Zikiar Alvin; Graham G Laurence; Bernell R Coleman; Aiqiu Zhao; Majd Hajj-Moussa; Georges E Haddad
Journal:  Can J Physiol Pharmacol       Date:  2011-03       Impact factor: 2.273

3.  Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

Authors:  Wenxia Chai; Ingrid M Garrelds; Udayasankar Arulmani; Regien G Schoemaker; Jos M J Lamers; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  Effects and interaction, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo.

Authors:  N N Aye; S Komori; K Hashimoto
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  Age-dependent differential crosstalk between alpha(1)-adrenergic and angiotensin receptors.

Authors:  Yan-fang Li; Shu-tian Shi
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.